Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 22% ± 5% | |
microglial cell | 9 studies | 26% ± 10% | |
retinal rod cell | 8 studies | 29% ± 11% | |
macrophage | 8 studies | 27% ± 10% | |
plasmacytoid dendritic cell | 8 studies | 22% ± 6% | |
naive B cell | 7 studies | 18% ± 2% | |
B cell | 7 studies | 22% ± 5% | |
amacrine cell | 6 studies | 31% ± 13% | |
dendritic cell | 6 studies | 21% ± 8% | |
mast cell | 6 studies | 20% ± 5% | |
epithelial cell | 5 studies | 26% ± 8% | |
retinal cone cell | 5 studies | 39% ± 17% | |
myeloid cell | 5 studies | 23% ± 4% | |
astrocyte | 5 studies | 36% ± 10% | |
ciliated cell | 4 studies | 19% ± 1% | |
glutamatergic neuron | 4 studies | 46% ± 19% | |
endothelial cell of lymphatic vessel | 4 studies | 21% ± 4% | |
monocyte | 4 studies | 22% ± 5% | |
oligodendrocyte | 4 studies | 22% ± 6% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 19% ± 3% | |
GABAergic amacrine cell | 3 studies | 48% ± 8% | |
precursor B cell | 3 studies | 25% ± 4% | |
retina horizontal cell | 3 studies | 19% ± 3% | |
mononuclear phagocyte | 3 studies | 18% ± 2% | |
muscle cell | 3 studies | 16% ± 1% | |
GABAergic neuron | 3 studies | 48% ± 9% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 6% | |
natural killer cell | 3 studies | 19% ± 2% | |
alveolar macrophage | 3 studies | 27% ± 7% | |
basal cell | 3 studies | 22% ± 6% | |
transit amplifying cell | 3 studies | 26% ± 12% | |
interneuron | 3 studies | 38% ± 18% | |
abnormal cell | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 741.82 | 180 / 180 | 100% | 17.78 | 430 / 430 |
stomach | 100% | 951.12 | 359 / 359 | 100% | 20.77 | 286 / 286 |
skin | 100% | 881.55 | 1808 / 1809 | 100% | 40.32 | 472 / 472 |
lung | 100% | 1104.40 | 577 / 578 | 100% | 20.01 | 1155 / 1155 |
bladder | 100% | 1391.95 | 21 / 21 | 100% | 24.26 | 503 / 504 |
prostate | 100% | 1080.93 | 245 / 245 | 100% | 22.72 | 501 / 502 |
uterus | 100% | 1045.79 | 170 / 170 | 100% | 26.62 | 458 / 459 |
thymus | 100% | 1088.90 | 652 / 653 | 100% | 30.52 | 604 / 605 |
intestine | 100% | 1459.10 | 966 / 966 | 100% | 23.37 | 525 / 527 |
breast | 100% | 1119.70 | 459 / 459 | 100% | 25.85 | 1113 / 1118 |
brain | 100% | 1919.10 | 2641 / 2642 | 99% | 23.47 | 701 / 705 |
esophagus | 100% | 1147.74 | 1445 / 1445 | 99% | 11.84 | 181 / 183 |
kidney | 100% | 1135.35 | 89 / 89 | 99% | 21.86 | 891 / 901 |
pancreas | 97% | 466.55 | 317 / 328 | 100% | 20.00 | 178 / 178 |
adrenal gland | 99% | 635.67 | 256 / 258 | 95% | 14.01 | 219 / 230 |
liver | 80% | 299.42 | 180 / 226 | 89% | 11.65 | 363 / 406 |
adipose | 100% | 1093.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1697.06 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 29.81 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 90.17 | 29 / 29 |
spleen | 100% | 1546.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.64 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.15 | 1 / 1 |
muscle | 99% | 937.40 | 798 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1061.27 | 916 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 900.38 | 846 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0014059 | Biological process | regulation of dopamine secretion |
GO_0060271 | Biological process | cilium assembly |
GO_0060159 | Biological process | regulation of dopamine receptor signaling pathway |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0048813 | Biological process | dendrite morphogenesis |
GO_0031175 | Biological process | neuron projection development |
GO_0008089 | Biological process | anterograde axonal transport |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0061002 | Biological process | negative regulation of dendritic spine morphogenesis |
GO_0001822 | Biological process | kidney development |
GO_0060041 | Biological process | retina development in camera-type eye |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0007596 | Biological process | blood coagulation |
GO_0032438 | Biological process | melanosome organization |
GO_0002092 | Biological process | positive regulation of receptor internalization |
GO_0061646 | Biological process | positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization |
GO_0048812 | Biological process | neuron projection morphogenesis |
GO_0048490 | Biological process | anterograde synaptic vesicle transport |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0060155 | Biological process | platelet dense granule organization |
GO_0001956 | Biological process | positive regulation of neurotransmitter secretion |
GO_0007613 | Biological process | memory |
GO_2000300 | Biological process | regulation of synaptic vesicle exocytosis |
GO_0071806 | Biological process | protein transmembrane transport |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0030496 | Cellular component | midbody |
GO_0016528 | Cellular component | sarcoplasm |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0042383 | Cellular component | sarcolemma |
GO_0043025 | Cellular component | neuronal cell body |
GO_0098686 | Cellular component | hippocampal mossy fiber to CA3 synapse |
GO_0043005 | Cellular component | neuron projection |
GO_0033162 | Cellular component | melanosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0014069 | Cellular component | postsynaptic density |
GO_0030426 | Cellular component | growth cone |
GO_0031083 | Cellular component | BLOC-1 complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0010008 | Cellular component | endosome membrane |
GO_0030424 | Cellular component | axon |
GO_1904115 | Cellular component | axon cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | DTNBP1 |
Protein name | Dystrobrevin binding protein 1 isoform 1 Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein) Dystrobrevin binding protein 1 |
Synonyms | BLOC1S8 My031 |
Description | FUNCTION: Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Associates with the BLOC-2 complex to facilitate the transport of TYRP1 independent of AP-3 function. Plays a role in synaptic vesicle trafficking and in neurotransmitter release. Plays a role in the regulation of cell surface exposure of DRD2. May play a role in actin cytoskeleton reorganization and neurite outgrowth. May modulate MAPK8 phosphorylation. Appears to promote neuronal transmission and viability through regulating the expression of SNAP25 and SYN1, modulating PI3-kinase-Akt signaling and influencing glutamatergic release. Regulates the expression of SYN1 through binding to its promoter. Modulates prefrontal cortical activity via the dopamine/D2 pathway. . |
Accessions | A6NFV8 ENST00000355917.7 ENST00000338950.9 [Q96EV8-2] D6RAX1 ENST00000515875.5 ENST00000622898.4 ENST00000506844.1 ENST00000462989.6 A0A087WYP9 D6RJC6 ENST00000511762.2 A0A0S2Z5U8 D6RCT8 D6RB80 Q96EV8 ENST00000344537.10 [Q96EV8-1] ENST00000509674.1 ENST00000513680.5 ENST00000510395.5 D6RID1 D6RAR7 |